New Gene Therapy for Hemophilia B Eliminates Need for Injections
A single intravenous infusion is now capable of freeing people with Hemophilia B from a lifetime of routine clotting factor injections.
Category Genetics
New Research: This Common Drug Reduces Alzheimer’s Risk by 30 Percent
A cheap, decades-old anti-seizure medication called levetiracetam may fundamentally change how we prevent Alzheimer's disease.
The Hormone Therapy Reducing Breast Cancer Risk by 50 Percent
Tamoxifen, a selective estrogen receptor modulator first approved by the FDA for breast cancer prevention in 1999, reduced the risk of invasive breast...
Clopidogrel Genetic Testing: Why Your Plavix May Not Be Working
If you or someone you care for takes clopidogrel — sold under the brand name Plavix — and has suffered a stroke, heart attack, or transient ischemic...
Gene Editing Drug Just Approved — The Science Behind CRISPR Medicine
The first gene editing drug built on CRISPR technology has already been approved and is treating patients right now.
Estrogen Patch vs. Pill for Menopause: Heart Risk Is Different for Each
If you are a postmenopausal woman weighing hormone therapy options, the short answer is that estrogen patches carry meaningfully lower cardiovascular risk...
Heart Attack Risk Drug That’s So Cheap You Can Get It for $4
The drug is colchicine, a centuries-old gout medication that costs as little as $4 for a 30-day supply at Walmart — no insurance or membership required.
Glucagon Injection: What Every Diabetic’s Family Member Should Know
If someone in your household lives with diabetes, knowing how to administer a glucagon injection could save their life.
Alpha-1 Antitrypsin Deficiency: The Genetic Lung Disease Few Know About
Alpha-1 antitrypsin deficiency is an inherited genetic condition in which the body fails to produce enough of a critical protein that protects the lungs...
Chronic Kidney Disease Drug Cuts Kidney Failure Risk by 30 Percent
A class of drugs originally developed for type 2 diabetes now reduces the risk of kidney failure by roughly 30 to 40 percent in patients with chronic...